Variability in Motor Threshold during Transcranial Magnetic Stimulation Treatment for Depression: Neurophysiological Implications
Brain Sciences · 26.08.2023 · 13 (9) · 1246
DOI: 10.3390/brainsci13091246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Sciences, online erschienen am 26.08.2023. Verfasst von Alexis Bourla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, 75012 Paris, France. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
The measurement of the motor threshold (MT) is an important element in determining stimulation intensity during Transcranial Magnetic Stimulation treatment (rTMS). The current recommendations propose its realization at least once a week. The variability in this motor threshold is an important factor to consider as it could translate certain neurophysiological specificities. We conducted a retrospective naturalistic study on data from 30 patients treated for treatment-resistant depression in an rTMS-specialized center. For each patient, weekly motor-evoked potential (MEP) was performed and several clinical elements were collected as part of our clinical interviews. Regarding response to treatment (Patient Health Questionnaire-9 (PHQ-9) before and after treatment), there was a mean difference of −8.88 (−21 to 0) in PHQ9 in the Theta Burst group, of −9.00 (−18 to −1) in the High-Frequency (10 Hz) group, and of −4.66 (−10 to +2) in the Low-Frequency (1 Hz) group. The mean improvement in depressive symptoms was 47% (p < 0.001, effect-size: 1.60). The motor threshold changed over the course of the treatment, with a minimum individual range of 1 point and a maximum of 19 points (total subset), and a greater concentration in the remission group (4 to 10) than in the other groups (3 to 10 in the response group, 1 to 8 in the partial response group, 3 to 19 in the stagnation group). We also note that the difference between MT at week 1 and week 6 was statistically significant only in the remission group, with a different evolutionary profile showing an upward trend in MT. Our findings suggest a potential predictive value of MT changes during treatment, particularly an increase in MT in patients who achieve remission and a distinct “break” in MT around the 4th week, which could predict nonresponse.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Hôpital Saint-Antoine, AP-HP, Sorbonne Université, 75012 Paris, France.
- ICRIN Psychiatry (Infrastructure of Clinical Research In Neurosciences-Psychiatry), Brain Institute (ICM), Sorbonne Université, INSERM, CNRS, 75013 Paris, France.
- Clariane, Medical Strategy and Innovation Department, 75008 Paris, France.
- NeuroStim Psychiatry Practice, 75005 Paris, France.
- Institut du Cerveau, Service de Psychiatrie Adulte de la Pitié-Salpêtrière, AP-HP, Sorbonne Université, ICM, 75013 Paris, France.
ORCID-Profile: Alexis Bourla, Stéphane Mouchabac
Zitieren
APA
Bourla, A., Mouchabac, S., Lorimy, L., Crette, B., Millet, B., & Ferreri, F. (2023). Variability in Motor Threshold during Transcranial Magnetic Stimulation Treatment for Depression: Neurophysiological Implications. Brain Sciences, 13(9), 1246. https://doi.org/10.3390/brainsci13091246
Vancouver
Bourla A, Mouchabac S, Lorimy L, Crette B, Millet B, Ferreri F. Variability in Motor Threshold during Transcranial Magnetic Stimulation Treatment for Depression: Neurophysiological Implications. Brain Sciences. 2023;13(9):1246. doi:10.3390/brainsci13091246
BibTeX
@article{Bourla2023,
author = {Bourla, Alexis and Mouchabac, Stéphane and Lorimy, Léonard and Crette, Bertrand and Millet, Bruno and Ferreri, Florian},
title = {Variability in Motor Threshold during Transcranial Magnetic Stimulation Treatment for Depression: Neurophysiological Implications},
journal = {Brain Sciences},
year = {2023},
volume = {13},
number = {9},
pages = {1246},
doi = {10.3390/brainsci13091246}
}
EUVIMED